Hence, these data indicate that CerS1-derived C18:0 ceramides in neurons of the hypothalamus do not promote the obesity-associated deterioration of glucose homeostasis, as opposed to their critical role in skeletal muscle and that of hypothalamic CerS6. The gene discussed is CERS6; the disease is obesity due to melanocortin 4 receptor deficiency.